With the banking and financial sectors in the developed economies especially the US – a segment that contributes a sizeable chunk to the domestic software services exports – under stress, analysts said there is a likelihood of further earnings downgrades in the sector that could weigh down shares of these companies in the near future.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,